Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats

被引:19
作者
Belayev, L
Becker, DA
Alonso, OF
Liu, YT
Busto, R
Ley, JJ
Ginsberg, MD
机构
[1] Univ Miami, Sch Med, Dept Neurol D45, Cerebral Vasc Dis Res Ctr, Miami, FL 33101 USA
[2] Florida Int Univ, Dept Chem, Miami, FL 33199 USA
关键词
oxygen radicals; reactive oxygen species; neuroprotection; traumatic brain injury; histopathological study; neurobehavioral outcome; rat;
D O I
10.3171/jns.2002.96.6.1077
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Stilbazulenyl nitrone (STAZN) is a second-generation azulenyl nitrone that has markedly enhanced antioxidant properties compared with those of conventional alpha-phenyl nitrones. In this study, the authors assessed the potential efficacy of STAZN in a rodent model of fluid-percussion brain injury, which results in a consistent cortical contusion. Methods. After anesthesia had been induced in normothermic Sprague-Dawley rats (brain temperature 36-36.5degreesC) by halothane-nitrous oxide, the animals were subjected to a right parietooccipital parasagittal fluid-percussion injury (1.5-2 atm). The agent (STAZN, 30 mg/kg; eight animals) or vehicle (dimethyl sulfoxide; eight animals) was administered intraperitoneally at 5 minutes and 4 hours after trauma. The neurological status of each rat was evaluated on Days 1, 2, and 7 postinjury (normal score 0, maximum injury 12). Seven days after trauma, the rat brains were perfusion fixed, coronal sections at various levels were digitized, and areas of contusion were measured. Treatment with STAZN significantly improved neurological scores on Days 2 and 7 postinjury compared with vehicle-treated rats. Administration of STAZN also significantly reduced the total contusion area by 63% (1.8 +/- 0.5 mm(2) in STAZN-treated animals compared with 4.8 +/- 2.1 mm(2) in vehicle-treated animals; p = 0.04) and the deep cortical contusion area by 60% (1.2 +/- 0.2 mm(2) in STAZN-treated animals compared with 2.9 +/- 1.2 mm(2) in vehicle-treated animals; p = 0.03). By contrast, hippocampal cell loss in the CA3 sector was unaffected by STAZN treatment. Conclusions. Therapy with STAZN, a novel potent antioxidant, administered following traumatic brain injury, markedly improves neurological and histological outcomes. Azulenyl nitrones appear to represent a promising class of neuroprotective agents for combating this devastating condition.
引用
收藏
页码:1077 / 1083
页数:7
相关论文
共 57 条
[1]   Azulenyl nitrones: Colorimetric detection of oxyradical end products and neuroprotection in the gerbil transient forebrain ischemia/reperfusion model [J].
Althaus, JS ;
Fleck, TJ ;
Becker, DA ;
Hall, ED ;
Vonvoigtlander, PF .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 24 (05) :738-744
[2]  
[Anonymous], FREE RADICAL DAMAGE
[3]   Oxidative stress following traumatic brain injury in rats [J].
Awasthi, D ;
Church, DF ;
Torbati, D ;
Carey, ME ;
Pryor, WA .
SURGICAL NEUROLOGY, 1997, 47 (06) :575-581
[4]   Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats [J].
Bareyre, FM ;
Saatman, KE ;
Raghupathi, R ;
McIntosh, TK .
JOURNAL OF NEUROTRAUMA, 2000, 17 (11) :1029-1039
[5]   Diagnostic and therapeutic applications of azulenyl nitrone spin traps [J].
Becker, DA .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 56 (7-8) :626-633
[6]  
Becker DA, 1998, ORG SYN TH, V4, P155
[8]   Redox behaviour of azulenyl nitrones: fully reversible one electron oxidation by cyclic voltammetry at potentials in the range of biological antioxidants [J].
Becker, DA ;
Natero, R ;
Echegoyen, L ;
Lawson, RC .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1998, (06) :1289-1291
[9]   RAT MIDDLE CEREBRAL-ARTERY OCCLUSION - EVALUATION OF THE MODEL AND DEVELOPMENT OF A NEUROLOGIC EXAMINATION [J].
BEDERSON, JB ;
PITTS, LH ;
TSUJI, M ;
NISHIMURA, MC ;
DAVIS, RL ;
BARTKOWSKI, H .
STROKE, 1986, 17 (03) :472-476
[10]   Bilateral ischemic tolerance of rat hippocampus induced by prior unilateral transient focal ischemia: Relationship to c-fos mRNA expression [J].
Belayev, L ;
Ginsberg, MD ;
Alonso, OF ;
Singer, JT ;
Zhao, WZ ;
Busto, R .
NEUROREPORT, 1996, 8 (01) :55-59